| [1] |
Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin，2018，68（6）：394-424.
|
| [2] |
Chen W，Zheng R，Baade PD，et al.Cancer statistics in China，2015[J].CA Cancer J.Clin，2016，66（2）：115-132.
|
| [3] |
Fearon ER，Vogelstein B.A Genetic Model for Colorectal Tumorigenesis[J].Cell，1990，61：759-767.
|
| [4] |
Dekker E，Tanis P J，Vleugels J，et al.Colorectal cancer[J].The Lancet，2019，394（10207）：1467-1480.
|
| [5] |
Pino MS，Chung DC.The chromosomal instability pathway in colon cancer[J].Gastroenterology，2010，138（6）：2059-2072.
|
| [6] |
Gehlenborg N，Research,TCGA，Atlas T，et al.Cancer Genome Atlas Network.Comprehensive molecular characterization of human colon and rectal cancer[J].Nature，2012，487（7407）：330-337.
|
| [7] |
Ilm K，Fuchs S，Mudduluru G，et al.MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer[J].Oncotarget，2016，7（33）：53443-53458.
|
| [8] |
Zhang X，Shi H，Tang H，et al.miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway[J].Int J Mol Med，2015，35（5）：1301-1308.
|
| [9] |
Ting W，Ling X，Rongrong J，et al.MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1[J].Acta Biochim Biophys Sin(Shanghai)，2017，49（5）：383-391.
|
| [10] |
Deng M，Zeng C，Lu X，et al.miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop[J].Cancer Lett，2017，403：175-185.
|
| [11] |
Li Z，Qian R，Zhang J，et al.MiR-218-5p targets LHFPL3 to regulate proliferation，migration，and epithelial-mesenchymal transitions of human glioma cells[J].Biosci Rep，2019，39（3）：1-14.
|
| [12] |
Bosman FT，Carneiro F，Hruban RH，et al.WHO Classification of Tumours of the Digestive System[M].4th Edition.Lyon：IARC，2010：134-165.
|
| [13] |
Slattery ML，Herrick JS，Pellatt DF，et al.MicroRNA profiles in colorectal carcinomas，adenomas and normal colonic mucosa：variations in miRNA expression and disease progression[J].Carcinogenesis，2016，37（3）：245-261.
|
| [14] |
Biker H，Alwers E，Arnold A，et al.The association between mutations in BRAF and colorectal cancer—specific survival depends on microsatellite status and tumor stage[J].Clin Gastruenterol Hepatol，2019，17（3）：455-462.
|
| [15] |
Zhang K，Li SW，Gu DY，et al.Genetic variants in circ-TUBB interacting with smoking can enhance colorectal cancer risk[J].Arch Toxicol，2020，94（1）：325-333.
|
| [16] |
Wu M，Kim YS，Ryu HS，et al.MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer：A systematic review and meta-analysis[J].Pathol Res Pract，2020，216（1）：152791.
|
| [17] |
Gattolliat CH，Uguen A，Pesson M，et al.MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas[J].Eur J Cancer，2015，51（3）：409-420.
|
| [18] |
Tatarano S，Chiyomaru T，Kawakami K，et al.miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer[J].Int J Oncol，2011，39（1）：13-21.
|
